We are live on ! Find out more
AACP

Advantage Alpha Capital Partners Portfolio holdings

AUM $332M
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$423M
AUM Growth
-$15.9M
Cap. Flow
-$17.8M
Cap. Flow %
-4.2%
Top 10 Hldgs %
18.16%
Holding
184
New
18
Increased
70
Reduced
65
Closed
31

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$7.06M
2
CECO icon
Ceco Environmental
CECO
+$5.6M
3
PRMB
Primo Brands
PRMB
+$5.29M
4
BOOT icon
Boot Barn
BOOT
+$4.77M
5
BECN
Beacon Roofing Supply, Inc.
BECN
+$4.28M

Top Sells

Rank Stock Value
1
HUBS icon
HubSpot
HUBS
+$8.84M
2
GGG icon
Graco
GGG
+$6.14M
3
PRMW
Primo Water Corporation
PRMW
+$5.04M
4
CNM icon
Core & Main
CNM
+$4.39M
5
WK icon
Workiva
WK
+$3.86M

Sector Composition

Rank Sector Weight
1 Industrials 37.8%
2 Technology 16.64%
3 Financials 12.59%
4 Healthcare 9.98%
5 Consumer Discretionary 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNM icon
151
Core & Main
CNM
$8.05B
$153 ﹤0.01%
3
-93,097
-100% -$4.39M
AZEK
152
DELISTED
The AZEK Co
AZEK
$142 ﹤0.01%
3
-69,513
-100% -$3.32M
TREX icon
153
Trex
TREX
$4.66B
$138 ﹤0.01%
2
-46,755
-100% -$3.29M
APPN icon
154
Appian
APPN
$3.04B
– –
-86,587
Closed -$2.96M
AXON
155
Axon Enterprise
AXON
$48.8B
– –
-5,139
Closed -$2.05M
CERT icon
156
Certara
CERT
$1.27B
– –
-160,156
Closed -$1.88M
CMPR icon
157
Cimpress
CMPR
$2.17B
– –
-35,796
Closed -$2.93M
COLL icon
158
Collegium Pharmaceutical
COLL
$786M
– –
-8,813
Closed -$341K
CRNX icon
159
Crinetics Pharmaceuticals
CRNX
$9B
– –
-8,640
Closed -$442K
CSTL icon
160
Castle Biosciences
CSTL
$1.02B
– –
-10,940
Closed -$312K
CYTK icon
161
Cytokinetics
CYTK
$10B
– –
-8,292
Closed -$438K
DH icon
162
Definitive Healthcare
DH
$85.7M
– –
-58,505
Closed -$262K
DYN icon
163
Dyne Therapeutics
DYN
$4.68B
– –
-10,737
Closed -$386K
FENC icon
164
Fennec Pharmaceuticals
FENC
$430M
– –
-52,876
Closed -$264K
GGG icon
165
Graco
GGG
$12.8B
– –
-70,219
Closed -$6.14M
GH icon
166
Guardant Health
GH
$21.7B
– –
-14,937
Closed -$343K
HBIO icon
167
Harvard Bioscience
HBIO
$36.1M
– –
-2,362
Closed -$63.5K
IBRX icon
168
ImmunityBio
IBRX
$8.53B
– –
-69,207
Closed -$257K
IMVT icon
169
Immunovant
IMVT
$8.51B
– –
-14,975
Closed -$427K
KRYS icon
170
Krystal Biotech
KRYS
$10.4B
– –
-2,289
Closed -$417K
LFUS icon
171
Littelfuse
LFUS
$10.3B
– –
-11,107
Closed -$2.95M
MDGL icon
172
Madrigal Pharmaceuticals
MDGL
$12.3B
– –
-1,643
Closed -$349K
NGVT icon
173
Ingevity
NGVT
$2.39B
– –
-53,609
Closed -$2.09M
NUVL
174
DELISTED
Nuvalent
NUVL
– –
-4,851
Closed -$496K
ORGO icon
175
Organogenesis Holdings
ORGO
$224M
– –
-101,558
Closed -$290K
4 5 6
7
8

Similar funds

CPA
Court Place Advisors Ellicott City, Maryland $332M AUM 16.16% 1-Year Est. Return
PAWA
Palo Alto Wealth Advisors Palo Alto, California $343M AUM 33.47% 1-Year Est. Return
EE
EWG Elevate Roseville, California $320M AUM 18.11% 1-Year Est. Return
GB
Gunma Bank Gunma, Japan $319M AUM 1.17% 1-Year Est. Return
SC
Solari Capital Palm Beach Gardens, Florida $318M AUM
SFG
Sterling Financial Group Pasadena, California $316M AUM 10.54% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
BCCM
Bridge Creek Capital Management West Barnstable, Massachusetts $360M AUM 16.27% 1-Year Est. Return

Advantage Alpha Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Advantage Alpha Capital Partners held 184 positions worth $423M, down 3.6% from $439M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Advantage Alpha Capital Partners withdrew a net $17.8M in Q4 2024, closing 31 positions and reducing 65 holdings. Its most notable exit was Graco, an estimated $6.14M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Advantage Alpha Capital Partners opened a new position in FTAI Aviation worth $6.9M.

  • Advantage Alpha Capital Partners's largest Q4 2024 buy was FTAI Aviation: 47,894 shares worth $6.9M.
  • Advantage Alpha Capital Partners added most to Beacon Roofing Supply, Inc. in Q4 2024, an estimated $4.28M increase.
  • Advantage Alpha Capital Partners's biggest Q4 2024 reduction was HubSpot, cutting an estimated $8.84M.
  • Advantage Alpha Capital Partners fully exited Graco in Q4 2024, selling an estimated $6.14M.
  • Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $423M portfolio in Q4 2024.
  • Advantage Alpha Capital Partners opened 18 new positions and closed 31 in Q4 2024.
  • Advantage Alpha Capital Partners's portfolio value fell 3.6% quarter-over-quarter to $423M.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.